Skip to content
  • ABOUT
  • AUTHOR GUIDELINES
  • AUTHORS/EDITORS
  • SUBSCRIPTIONS
  • CONTACT US
  • MY ACCOUNT
FacebookTwitterGoogle+LinkedInInstagram
MedWorks Media Logo MedWorks Media Logo MedWorks Media Logo
  • HOME
  • JOURNALS
    • ARTICLES IN PRESS
    • PSYCHOPHARMACOLOGY BULLETIN
    • FULL ISSUE STACKED PDFs
    • T.E.N.
    • MENTAL FITNESS
    • PSI
    • ONCOLOGY SPECTRUMS
  • PROJECTS
    • JOURNAL SUPPLEMENTS
    • PHYSICIAN ACADEMY SERIES
    • POCKET REFERENCE GUIDES
    • TEACHING MONOGRAPHS
    • MEDWORKS REPRINT SERIES
  • RESOURCES
    • PSYCHOTROPICS A-Z
    • PSYCHOTROPIC PRESCRIBING INFORMATION
    • PSYCHOTROPIC DOSAGE RANGES
    • PSYCHOPHARMACOLOGY 101
    • PSYCHIATRIC RATING SCALES
  • NEWS
    • WE KNOW PSYCHIATRY
    • FEATURED ARTICLES
Home/major-depressive-disorder
  • Sort by Date
    • Sort by Name
    • Sort by Price
    • Sort by Date
    • Sort by Popularity
    • Sort by Rating
  • Show 20 Products
    • Show 20 Products
    • Show 40 Products
    • Show 60 Products
  • Cariprazine

    Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

    $30.00
    Add to cart Details
  • Psychopharmacology Bulletin

    Psychopharmacology Bulletin VOL 48 No. 4, 2018 – Full Issue Stacked PDF

    $90.00
    Add to cart Details
  • Psychopharmacology Bulletin

    Psychopharmacology Bulletin VOL 48 No. 3, 2018 – Full Issue Stacked PDF

    $90.00
    Add to cart Details
  • Dermatomyositis

    Major Depressive Disorder Following Dermatomyositis: A Case Linking Depression with Inflammation

    $30.00
    Add to cart Details
  • Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

    $0.00
    Add to cart Details
  • A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder

    $30.00
    Add to cart Details
  • The Sex Effects Scale: Pilot Validation in a Healthy Population

    The Sex Effects Scale: Pilot Validation in a Healthy Population

    $30.00
    Add to cart Details
  • Jeffrey E. Kelsey, MD, PhD: Social Anxiety: An Often Silent Disorder

    $30.00
    Add to cart Details
  • Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

    $30.00
    Add to cart Details
  • Paroxetine Treatment of Major Depressive Disorder

    $30.00
    Add to cart Details
  • The MentalFitness Physician Resource Series

    Depression Rating Scales – A Doctor’s Guide

    $15.00
    Add to cart Details
  • Efficacy of Omega-3 Fatty Acids in Mood Disorders

    $30.00
    Add to cart Details
  • Analysis of Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo

    $30.00
    Add to cart Details
  • Assessing Rates and Predictors of Tachyphylaxis

    $30.00
    Add to cart Details
  • Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

    $30.00
    Add to cart Details

Contact Us

2205 Rockefeller Lane Unit B

Phone: 310-374-1300

Email: ceo@medworksmedia.com

Web: MedWorksMedia.com

Privacy Policy
Cookie Policy

Useful Links

About Us

Articles In Press

Author Guidelines

Authors and Editorial Advisors

Journal Supplements

Psychopharmacology 101

Psychopharmacology Bulletin

Psychotropics A-Z

Subscriptions

Recent Psychopharmacology Bulletin Articles

  • Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial $30.00
  • Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital $30.00
  • Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study $30.00

Brain Science Blogs

  • Improved efficacy of pregabalin by restoring plasma vitamin D levels in migraine: a case report. February 15, 2019
  • Successful Resolution of Prominent Somatic Delusions following Bi-temporal Electroconvulsive Therapy in a patient with Treatment- Resistant Schizoaffective disorder February 15, 2019
  • Combination of Ketamine and Naltrexone Shows Promise for Addiction Treatments and Depression January 18, 2019
Copyright 2019 MedWorks Media Inc | All Rights Reserved
FacebookTwitterGoogle+LinkedInInstagram